ConductScience.org, home

Paper708015

Inactivation of metronidazole by anaerobic and aerobic bacteria.

Ralph ED and 1 other. Antimicrob Agents Chemother, 1978. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Inactivation of metronidazole by anaerobic and aerobic bacteria. Papers, record 708015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/708015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivation of metronidazole by anaerobic and aerobic bacteria.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ralph EDE D
2Clarke DAD A

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
MetronidazoleMajor topic
Drug Resistance, Microbial

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1233729Antimicrobial activity of metronidazole in anaerobic bacteria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/233729PubMed
2895722Interaction of metronidazole with nucleic acids in vitro.Mol Pharmacol1977https://conductscience.org/library/papers/895722PubMed
3893242Treatment with metronidazole of 48 patients with serious anaerobic infections.J Antimicrob Chemother1977https://conductscience.org/library/papers/893242PubMed
4791102Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/791102PubMed
54977825Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole.Br J Vener Dis1969https://conductscience.org/library/papers/4977825PubMed
64364702The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.Biochem Pharmacol1974https://conductscience.org/library/papers/4364702PubMed
74451343Pharmacokinetics of metronidazole as determined by bioassay.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4451343PubMed
8172007Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/172007PubMed
94635396Metronidazole versus anaerobes. In vitro data and initial clinical observations.Calif Med1972https://conductscience.org/library/papers/4635396PubMed
101096810Treatment of anaerobic infections with metronidazole.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1096810PubMed
111107293The antibacterial activity of netronidazole.J Antimicrob Chemother1975https://conductscience.org/library/papers/1107293PubMed
121083712Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1083712PubMed
131185017Bioassay of metronidazole with either anaerobic or aerobic incubation.J Infect Dis1975https://conductscience.org/library/papers/1185017PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
35610666Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial.Trials2022https://conductscience.org/library/papers/35610666PubMed
33262350Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.Nat Commun2020https://conductscience.org/library/papers/33262350PubMed
32487244Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance.Parasit Vectors2020https://conductscience.org/library/papers/32487244PubMed
25999919Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance.Front Microbiol2015https://conductscience.org/library/papers/25999919PubMed
11368258Effect of metronidazole on the growth of vaginal lactobacilli in vitro.Infect Dis Obstet Gynecol2001https://conductscience.org/library/papers/11368258PubMed
10448372Recalcitrant vaginal trichomoniasis.Sex Transm Infect1999https://conductscience.org/library/papers/10448372PubMed
7106931Anaerobic bacterial infections in children-Part II.Indian J Pediatr1982https://conductscience.org/library/papers/7106931PubMed
7039761Metronidazole in a single dose for the treatment of trichomoniasis. Failure of a 1-g single dose.Br J Vener Dis1982https://conductscience.org/library/papers/7039761PubMed
7000306Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.Br J Vener Dis1980https://conductscience.org/library/papers/7000306PubMed
6983379Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.Br J Vener Dis1982https://conductscience.org/library/papers/6983379PubMed
6968175Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale).Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6968175PubMed
6752209Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.J Clin Pathol1982https://conductscience.org/library/papers/6752209PubMed
6340904Clinical pharmacokinetics of metronidazole.Clin Pharmacokinet1983https://conductscience.org/library/papers/6340904PubMed
6286503[Antibiotic resistance of anaerobic bacteria (author's transl)].Infection1982https://conductscience.org/library/papers/6286503PubMed
6264842Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6264842PubMed
6255861Relationship between metronidazole metabolism and bactericidal activity.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6255861PubMed
3147238Trichomonal vaginitis refractory to treatment: case report.Genitourin Med1988https://conductscience.org/library/papers/3147238PubMed
2807288Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports.Genitourin Med1989https://conductscience.org/library/papers/2807288PubMed
2332245Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.Infection1990https://conductscience.org/library/papers/2332245PubMed
1498765Gardnerella vaginalis: characteristics, clinical considerations, and controversies.Clin Microbiol Rev1992https://conductscience.org/library/papers/1498765PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/708015

GET https://conductscience.org/api/papers/v1/708015/authors